MIP Search | Managing Intellectual Property

Pharmaceutical patent successfully opposed

Boehringer Ingelheim Pharmaceuticals filed a patent application titled "Pharmaceutical composition". The invention relates to a paediatric suspension of nevirapine hemihydrate. The application was filed with a total of six claims and upon its examination, the examiner raised objections on the grounds of non-patentability and definitiveness of the claims. The applicant, in compliance with the objections, then amended the claims.

Managing IP Correspondent, August 31 2008

EPO rulings clarify biotech protection

James Nurton, London

Managing IP Correspondent, December 01 2008

The IP risks of throwing out the brand

Starbucks is opening a series of individually branded neighbourhood cafes that barely reference the internationally famous Starbucks brand. Jennifer Miremadi assesses the IP implications

Managing IP Correspondent, November 01 2009

A bitter pill

The Japanese courts recently vetoed a drug company's efforts to stop generic rivals from selling their products in lookalike packaging. John Tessensohn and Shusaku Yamamoto explain what the trade dress decision means for the pharmaceutical industry in one of the world's most lucrative drugs markets

Managing IP Correspondent, September 30 2006

Utynam's Heirs

A monthly column devoted to IP curiosities and controversies, named in honour of John of Utynam - who received the world's first recorded patent in 1449

Managing IP Correspondent, September 30 2008

Blow to Louis Vuitton in US dilution case

A US appeal court has ruled that a range of dog toys called Chewy Vuiton does not dilute LVMH's famous Louis Vuitton mark

Managing IP Correspondent, December 01 2007

Utynam's Heirs

A monthly column devoted to IP curiosities and controversies, named in honour of John of Utynam - who received the world's first recorded patent in 1449

Managing IP Correspondent, March 01 2007

Life sciences: a legal and regulatory update

Cedric Lam and Isabella Liu of law firm Dorsey & Whitney examine the most important legal and regulatory developments in China in recent years and explain what they mean for the protection and commercialisation of life sciences innovations

Managing IP Correspondent, March 31 2009

How Hong Kong fights the war on fakes

Hong Kong used to be a counterfeit buyer's paradise. But over the past 10 years Customs officials have upped their efforts to drive the sellers from the streets and smash the syndicates that control the trade. Peter Ollier followed a team of officers over three days to find out how successful they have been

Managing IP Correspondent, March 31 2007

Jeffery West wins jWest spat

This was an opposition brought by Mark Richard Jeffery and Guy Anthony (the opponents), owners of the registered mark Jeffery-West in Class 25, against Nautical Concept (the applicant) who applied to register jWEST as a trade mark in Class 25 for similar goods (shoes and footwear).

Managing IP Correspondent, December 01 2006

Search results for